In this study, NRG1 fusions were observed in lung cancer, colorectal cancer, breast cancer, gastric cancer, liver cancer, esophageal cancer, pancreatic cancer, prostate cancer, and medulloblastoma. This evidence concerns the gene NRG1 and Familial prostate cancer.